Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study Using Oral Capsule Fecal Microbiota Transplant To Decolonize Gastrointestinal Carbapenem-Resistant Enterobacteriaceae (CRE)

NCT03527056 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT03527056
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03527056 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study Using Oral Capsule Fecal Microbiota Transplant To Decolonize Gastrointestinal Carbapenem-Resistant Enterobacteriaceae (CRE)
Lead sponsor
University of California, Los Angeles
Phase
Phase 1
Overall status
Withdrawn
Start date
June 30, 2019
Completion date
September 24, 2019
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

enterobacteriaceae infections, fecal microbiota transplantation